☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
chronic inflammatory diseases
Boehringer Ingelheim's Cyltezo (biosimilar- adalimumab) Receives the US FDA's sBLA Approval as the 1st Interchangeable Biosimilar...
October 18, 2021
Amgen Collaborates with Orion for Commercialization of Amgevita (adalimumab- biosimilar) in Finland
October 25, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.
